The coronavirus has killed six fully vaccinated people in the Seychelles, which is suffering heightened Covid-19 infections despite inoculating a greater proportion of its people than any other nation.
Of those, five had taken Covishield, a version of the AstraZeneca Plc vaccine made in India, and one had been given Sinopharm, Jude Gedeon, the island nation’s public health commissioner said at a press conference on Thursday. Covishield has mainly been reserved for people over 60 in the Seychelles.
The rise in infections, which surged at the beginning of May and has remained at elevated levels ever since, is likely due to the arrival of the highly-transmissible delta variant, which was first identified in India, Gedeon said.
ALSO READ: India to dispatch ‘Covishield’ vaccine to Myanmar, Seychelles, Mauritius
“It looks like delta came in Seychelles in May which explain the surge at the beginning of May,” Gedeon said. “We presume that the majority of cases we got in May was from that variant.”
The palm-fringed archipelago had rushed to inoculate its 98,000 people so that it could reopen to tourism, the lifeblood of its economy. It has now had to impose restrictions on gatherings and opening times for bars and restaurants.
“For the last three weeks a team of experts from World Health Organization and Africa Centers for Disease Control have been working with us to evaluate our vaccination rate, data and response,” Gedeon said. “They will produce a report which will help us decide on the strategy to be used moving forward in terms of vaccination, measures etc.”
Frequent genomic studies have been reccomended, he said.
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
